Does AMIVANTAMAB Cause Dermatitis acneiform? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Dermatitis acneiform have been filed in association with AMIVANTAMAB (Rybrevant). This represents 4.6% of all adverse event reports for AMIVANTAMAB.
34
Reports of Dermatitis acneiform with AMIVANTAMAB
4.6%
of all AMIVANTAMAB reports
2
Deaths
15
Hospitalizations
How Dangerous Is Dermatitis acneiform From AMIVANTAMAB?
Of the 34 reports, 2 (5.9%) resulted in death, 15 (44.1%) required hospitalization, and 1 (2.9%) were considered life-threatening.
Is Dermatitis acneiform Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMIVANTAMAB. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does AMIVANTAMAB Cause?
Infusion related reaction (62)
Rash (61)
Pulmonary embolism (41)
Thrombocytopenia (33)
Paronychia (29)
Diarrhoea (25)
Pneumonitis (24)
Dyspnoea (23)
Nausea (23)
Neutropenia (23)
What Other Drugs Cause Dermatitis acneiform?
PANITUMUMAB (758)
FLUOROURACIL (508)
CETUXIMAB (425)
OXALIPLATIN (410)
ERLOTINIB (409)
LEUCOVORIN (252)
IRINOTECAN (242)
BEVACIZUMAB (191)
ADALIMUMAB (162)
AFATINIB (144)
Which AMIVANTAMAB Alternatives Have Lower Dermatitis acneiform Risk?
AMIVANTAMAB vs AMIVANTAMAB-VMJW
AMIVANTAMAB vs AMLODIPINE
AMIVANTAMAB vs AMLODIPINE BESILATE
AMIVANTAMAB vs AMLODIPINE\ATORVASTATIN
AMIVANTAMAB vs AMLODIPINE\BENAZEPRIL